VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
ASX Limited vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ASX Limited
ASX · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Pfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: ASX Limited leads (80 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: ASX Limited has 4 segments (31.5% in Markets); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Primary market structure: Duopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: ASX Limited has 4 moat types across 3 domains; Pfizer Inc. has 8 across 3.
Primary market context
ASX Limited
Markets
Trading venues for Australian cash equities and exchange-traded derivatives (futures, options)
Australia
Brokers/market participants, proprietary trading firms, institutional investors
Market operator / trading venue
31.5%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
ASX Limited strengths
Pfizer Inc. strengths
Segment mix
ASX Limited segments
Full profile >Listings
Quasi-Monopoly
Markets
Duopoly
Technology & Data
Competitive
Securities & Payments
Monopoly
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.